A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...
A research team investigates how genome editing can be harnessed to accelerate cassava breeding and improve key traits.
This study shows that RNA decay rather than the presence of premature termination codons triggers a TA-like response.
News-Medical.Net on MSN5d
Yale scientists develop advanced CRISPR tool to study complex genetic interactionsAdvances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases.
The results of this work reveal how an alternative splicing mechanism regulates an essential factor for neuronal identity.
Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...
CRISPR Therapeutics AG (CRSP) closed at $41.17 in the latest trading session, marking a -1.84% move from the prior day. Biotech is an area that may offer your portfolio growth today and earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback